FDA eases labeling, clarifies IVD requirements in COVID transition guidances

Regulatory NewsRegulatory NewsAdvertising, Promotion and LabelingComplianceDiagnostics/IVDsMedical DevicesNorth AmericaRegulatory Intelligence/Policy